文献速递临床试验与 GCP基础与转化研究

右美托咪定与静脉对乙酰氨基酚预防心脏术后谵妄:DEXACET试验方案

Dexmedetomidine and intravenous acetaminophen for the prevention of postoperative delirium following cardiac surgery (DEXACET trial): protocol for a prospective randomized controlled trial.
PubMed 文献 · Trials · 2018-06-22

DEXACET试验为前瞻性、随机、安慰剂对照、双盲、析因设计,纳入60岁及以上接受体外循环心脏手术患者,随机分配至四种术后镇痛镇静方案之一,评估谵妄发生率及术后认知下降等结局,计划分析120例至少接受一剂研究药物的患者。

要点

  • 纳入≥60岁体外循环心脏手术患者,随机接受对乙酰氨基酚联合右美托咪定或丙泊酚等四种方案。
  • 主要结局为谵妄发生率,采用CAM或CAM-ICU评估。
  • 次要结局包括术后认知下降(MoCA)、谵妄持续时间、镇痛需求、住院时长及不良事件。

核心结论

  • 该试验旨在评估术后静脉对乙酰氨基酚联合右美托咪定或丙泊酚能否降低心脏手术患者谵妄发生率。

研究设计与样本

  • 前瞻性、随机、安慰剂对照、双盲、析因试验,纳入至少60岁接受体外循环心脏手术(包括CABG及CABG/瓣膜联合手术)的患者。
  • 随机分配至四种术后镇痛镇静方案:对乙酰氨基酚联合右美托咪定、对乙酰氨基酚联合丙泊酚、右美托咪定联合安慰剂、丙泊酚联合安慰剂。
  • 计划对120例至少接受一剂研究药物的随机患者进行改良意向性分析。

关键数值与推荐

  • 主要结局为谵妄发生率,采用CAM或CAM-ICU评估。
  • 次要结局包括术后认知下降(采用MoCA评估)、谵妄持续时间、术后镇痛需求、住院时长及不良事件发生率。

临床怎么用

  • 若取得阳性结果,可能指导简单有效的实践改变以降低心脏术后认知相关并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative delirium is common in elderly cardiac surgery patients. It is multifactorial and is influenced by the patient's baseline status and the nature of the medical and surgical interventions that the patient receives. Some of these factors are potentially modifiable, including postoperative sedation and analgesia protocols. This study has been designed to evaluate the effectiveness of postoperative intravenous acetaminophen in conjunction with either dexmedetomidine or propofol in decreasing the incidence of delirium. METHODS: This is a prospective, randomized, placebo-controlled, double-blinded, factorial trial that includes patients who are at least 60 years old and who are undergoing cardiac surgeries involving cardiopulmonary bypass, including coronary artery bypass graft (CABG) and combined CABG/valve surgeries. Patients are randomly assigned to receive one of four postoperative analgesic-sedation regimens: (1) acetaminophen and dexmedetomidine, (2) acetaminophen and propofol, (3) dexmedetomidine and placebo, or (4) propofol and placebo. The primary outcome, incidence of delirium, will be assessed with the Confusion Assessment Method (CAM or CAM-ICU). The secondary outcome, postoperative cognitive decline, will be assessed with the Montreal Cognitive Assessment. Additional secondary outcomes, including duration of delirium, postoperative analgesic requirement, length of stay, and incidence of adverse events, will also be reported. Data will be analyzed in 120 randomly assigned patients who received at least one dose of the study medication(s) on a modified intention-to-treat basis. DISCUSSION: This study has been approved by the institutional review board at Beth Israel Deaconess Medical Center, and the trial is currently recruiting. This study will systematically examine the implications of modification in postoperative sedative/analgesic protocols after cardiac surgery, specifically for short- and long-term cognitive outcomes. Any positive outcomes from this study could direct simple yet effective practice changes aimed to reduce morbidity. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02546765 , registered January 13, 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Shankar P, Mueller A, Packiasabapathy S, et al. Dexmedetomidine and intravenous acetaminophen for the prevention of postoperative delirium following cardiac surgery (DEXACET trial): protocol for a prospective randomized controlled trial. Trials. 2018. PMID: 29929533. doi:10.1186/s13063-018-2718-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。